Devyser NIPT RHD
Benefit from proven, highly sensitive technology to conduct accurate non-invasive screening for fetal RHD that helps clinicians avoid untargeted and unnecessary treatment.
Benefit from proven, highly sensitive technology to conduct accurate non-invasive screening for fetal RHD that helps clinicians avoid untargeted and unnecessary treatment.
Welcome to Sero’s latest range of quality control materials.
The 2024-2025 SERO Quality Control Product Catalogue highlights a comprehensive range of high-quality control materials designed for clinical laboratories.
Products are for professional/laboratory use only.
LGC SeraCare offers a wide range of biological materials to help achieve consistent product quality.